메뉴 건너뛰기




Volumn 121, Issue 5, 2003, Pages 735-737

Voriconazole treatment of fungal scleritis and epibulbar abscess resulting from scleral buckle infection

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; ITRACONAZOLE; KETOCONAZOLE; METHYLPREDNISOLONE ACETATE; PREDNISOLONE ACETATE; VORICONAZOLE;

EID: 0037991477     PISSN: 00039950     EISSN: None     Source Type: Journal    
DOI: 10.1001/archopht.121.5.735     Document Type: Article
Times cited : (31)

References (9)
  • 1
    • 0031028655 scopus 로고    scopus 로고
    • Activity of voriconazole (UK-109,496) against clinical isolates of Aspergillus species and its effectiveness in an experimental model of invasive pulmonary aspergillosis
    • Murphy M, Bernard EM, Ishimaru T, Armstrong D. Activity of voriconazole (UK-109,496) against clinical isolates of Aspergillus species and its effectiveness in an experimental model of invasive pulmonary aspergillosis. Antimicrob Agents Chemother. 1997;41:696-698.
    • (1997) Antimicrob Agents Chemother , vol.41 , pp. 696-698
    • Murphy, M.1    Bernard, E.M.2    Ishimaru, T.3    Armstrong, D.4
  • 2
    • 0030744632 scopus 로고    scopus 로고
    • In vitro evaluation of voriconazole against some clinically important fungi
    • McGinnis MR, Pasarell L, Sutton DA, et al. In vitro evaluation of voriconazole against some clinically important fungi. Antimicrob Agents Chemother. 1997;41:1832-1834.
    • (1997) Antimicrob Agents Chemother , vol.41 , pp. 1832-1834
    • McGinnis, M.R.1    Pasarell, L.2    Sutton, D.A.3
  • 3
    • 0032418143 scopus 로고    scopus 로고
    • In vitro activity of voriconazole, itraconazole, and amphotericin B against filamentous fungi
    • Johnson EM, Szekely A, Warnock DW. In vitro activity of voriconazole, itraconazole, and amphotericin B against filamentous fungi. J Antimicrob Chemother. 1998;42:741-745.
    • (1998) J Antimicrob Chemother , vol.42 , pp. 741-745
    • Johnson, E.M.1    Szekely, A.2    Warnock, D.W.3
  • 4
    • 0037205542 scopus 로고    scopus 로고
    • Voriconazole: Better chances for patients with invasive mycosis
    • Ghannoum MA, Kuhn DM. Voriconazole: better chances for patients with invasive mycosis. Eur J Med Res. 2002;7:242-256.
    • (2002) Eur J Med Res , vol.7 , pp. 242-256
    • Ghannoum, M.A.1    Kuhn, D.M.2
  • 5
    • 0036498964 scopus 로고    scopus 로고
    • Efficacy and safety of voriconazole in the treatment of acute invasive aspergillosis
    • Denning DW, Ribaud P, Milpied N, et al. Efficacy and safety of voriconazole in the treatment of acute invasive aspergillosis. Clin Infect Dis. 2002;34:563-571.
    • (2002) Clin Infect Dis , vol.34 , pp. 563-571
    • Denning, D.W.1    Ribaud, P.2    Milpied, N.3
  • 6
    • 0037165259 scopus 로고    scopus 로고
    • Vori-conazole compared with liposomal amphotericin B for empirical antifungal therapy in patients with neutropenia and persistent fever
    • Walsh TJ, Pappas P, Winston DJ, et al. Vori-conazole compared with liposomal amphotericin B for empirical antifungal therapy in patients with neutropenia and persistent fever. N Engl J Med. 2002;346:225-234.
    • (2002) N Engl J Med , vol.346 , pp. 225-234
    • Walsh, T.J.1    Pappas, P.2    Winston, D.J.3
  • 7
    • 0033880667 scopus 로고    scopus 로고
    • Successful treatment of ocular invasive mould infection (fusariosis) with the new antifungal agent voriconazole
    • Reis A, Sundmacher R, Tintelnot K, Agostini H, Jensen HE, Althaus C. Successful treatment of ocular invasive mould infection (fusariosis) with the new antifungal agent voriconazole. Br J Ophthalmol. 2000;84:932-933.
    • (2000) Br J Ophthalmol , vol.84 , pp. 932-933
    • Reis, A.1    Sundmacher, R.2    Tintelnot, K.3    Agostini, H.4    Jensen, H.E.5    Althaus, C.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.